Director, Commercial Strategy

United States·Bothellexecutive

OtherCommercial Strategy

0 views0 saves0 applied

Apply Now

Quick Summary

Overview

Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies.

Technical Tools

OtherCommercial Strategy

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

Position Overview

The Director, Commercial Strategy is responsible for advancing key strategic initiatives across the commercial organization essential to Immunome’s launch of varegacestat and continued growth into a commercial organization. The role will lead varegacestat international commercialization strategy and key strategic initiatives across commercial planning & business management. The role requires strong business acumen, organizational agility, and the ability to navigate uncertainty while executing on core commercial priorities

Responsibilities